Theravance Biopharma, Inc.

Nasdaq:TBPH

Pharmaceutical Preparations·GEORGE TOWN, GRAND CAYMAN, CA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-K	FY 2024	12/31/24	3/7/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
10-Q	Q2 2024	6/30/24	8/8/24	→
↓

Earnings Releases (8-K)

25 shown

Filed	Period
3/3/26	Q1 FY2026	→
11/10/25	Q4 FY2025	→
8/12/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
2/26/25	Q1 FY2025	→
11/12/24	Q4 FY2024	→
↓

News (8-K)

55 shown

Filed	Type	Description
1/12/26	Reg FD	Regulation FD Disclosure	→
12/8/25	Other	Other Events	→
8/25/25	Other	Other Events	→
8/20/25	Other	Other Events	→
6/26/25	Other	Other Events	→
6/6/25	Other	Other Events	→
↓

Prospectuses & Registrations

26 shown

Filed	Form	Description
3/4/22	S-8	S-8	→
6/25/21	424B5	424B5	→
6/24/21	424B5	424B5	→
3/4/21	S-8	S-8	→
9/1/20	S-3ASR	S-3ASR	→
3/3/20	S-8	S-8	→
↓

Filing History(1001 filings)

TypeDateAccessionPeriodSize

8-K

Mar 3, 2026

0001104659-26-022572FORM 8-K

Mar 3, 2026

266.5 KB

Feb 24, 2026

0001302443-26-000002

Feb 20, 2026

6.2 KB

Feb 24, 2026

0001961289-26-000002

Feb 20, 2026

4.8 KB

Feb 24, 2026

0002012524-26-000002

Feb 20, 2026

4.8 KB

Feb 24, 2026

0001966698-26-000002

Feb 20, 2026

4.8 KB

Feb 24, 2026

0001898490-26-000002

Feb 20, 2026

4.8 KB

SCHEDULE 13G/A

Feb 17, 2026

0001493152-26-007116

—

9.6 KB

8-K

Jan 12, 2026

0001104659-26-002726FORM 8-K

Jan 12, 2026

13.7 MB

8-K

Dec 8, 2025

0001104659-25-119032FORM 8-K

Dec 8, 2025

11.1 MB

Dec 5, 2025

0001898490-25-000008

Dec 3, 2025

8.1 KB

144

Dec 3, 2025

0001950047-25-009691

—

6.4 KB

Dec 1, 2025

0001256230-25-000009

Nov 26, 2025

9.2 KB

144

Nov 26, 2025

0001950047-25-009394

—

7.1 KB

Nov 24, 2025

0001961289-25-000006

Nov 20, 2025

4.8 KB

Nov 24, 2025

0002012524-25-000006

Nov 20, 2025

4.8 KB

Nov 24, 2025

0001966698-25-000006

Nov 20, 2025

4.8 KB

Nov 24, 2025

0001898490-25-000006

Nov 20, 2025

4.8 KB

Nov 21, 2025

0001302443-25-000008

Nov 19, 2025

9.2 KB

4/A

Nov 14, 2025

0001256230-25-000007

Nov 11, 2025

11.0 KB

Nov 13, 2025

0001256230-25-000006

Nov 11, 2025

10.5 KB

10-Q

Nov 12, 2025

0001104659-25-11038210-Q

Sep 30, 2025

8.3 MB

144

Nov 12, 2025

0001950047-25-008708

—

7.2 KB

8-K

Nov 10, 2025

0001104659-25-109146FORM 8-K

Nov 10, 2025

5.8 MB

8-K

Aug 25, 2025

0001104659-25-082048FORM 8-K

Aug 25, 2025

226.0 KB

Aug 22, 2025

0001415889-25-022803

Aug 20, 2025

6.2 KB

25 filings shown

Filed	Form	Description
4/10/25	DEF 14A	FORM-DEF 14A	→
4/5/24	DEF 14A	DEF 14A	→
12/21/23	DEFA14A	DEFA14A	→
4/11/23	DEFA14A	DEFA14A	→
4/11/23	DEFA14A	DEFA14A	→
3/28/23	DEF 14A	DEF 14A	→
↓

Theravance Biopharma, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1001 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/24/26	4	4	→
2/24/26	4	4	→
2/24/26	4	4	→
2/24/26	4	4	→
2/24/26	4	4	→
12/5/25	4	4	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/3/25	144	144	→
11/26/25	144	144	→
11/12/25	144	144	→
7/14/25	144	144	→
6/2/25	144	144	→
↓